A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors | MicrobiomeTrials← Back to trialsNCT07277413
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-03-04Est. Completion: 2028-04-30
Enrollment target: 260 participants Locations- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida, United States
- Nebraska Cancer Specialists, Omaha, Nebraska, United States
- Columbia University Irving Medical Center, New York, New York, United States
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute, Nashville, Tennessee, United States
- START Dallas Fort Worth, Fort Worth, Texas, United States
- MD Anderson, Houston, Texas, United States
- NEXT Oncology Houston, Houston, Texas, United States
- NEXT Oncology Dallas, Irving, Texas, United States
- START Mountain Region, LLC, West Valley City, Utah, United States
- NEXT Oncology Virginia, Fairfax, Virginia, United States
- Swedish Cancer Institute, Seattle, Washington, United States
Other microbiome trials you might be interested in
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Esophageal CarcinomaGastroesophageal Junction AdenocarcinomaHepatocellular CarcinomaLocally Advanced Urothelial Carcinoma
Lung Non-Small Cell Carcinoma
Malignant Solid Neoplasm
Metastatic Colorectal Carcinoma
Metastatic Cutaneous Melanoma
Metastatic Esophageal Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Urothelial Carcinoma
Recurrent Esophageal Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma
Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Colorectal Cancer AJCC v8
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Unresectable Cutaneous Melanoma
Unresectable Esophageal Squamous Cell Carcinoma
Urothelial Carcinoma
Unresectable Urothelial Carcinoma
This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setti…
Jacksonville, United StatesEst. completion Dec 31, 2026
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)Nonsmall Cell Lung CancerColorectal Cancer (CRC)
This study is to evaluate the safety and tolerability to determine (i) the recommended Phase 2 dose (RP2D) of VMD-102 (P…
Scottsdale, United StatesEst. completion May 2031
Breast NeoplasmsCarcinoma, Non-Small-Cell Lung
This is a phase I, open label first in human study to evaluate the imaging performance, safety, biodistribution and phar…
Groningen, NetherlandsEst. completion Oct 31, 2028